Navidea Biopharmaceuticals, Inc.
Climate Impact & Sustainability Data (2015, 2016, 2016-06-30)
Reporting Period: 2015
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Time taken to obtain financial information from subsidiary, Macrophage Therapeutics, Inc.
- Material weakness in internal controls relating to Macrophage Therapeutics, Inc. and compliance with Company control policies
- Settlement Agreement with Platinum Management (NY) LLC and affiliates regarding matters addressed in the Schedule 13D
Mitigation Strategies
- Working to file the 2015 Form 10-K by March 30, 2016
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2016
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Significant management time and resources were diverted from the Company’s normal process of reviewing and completing the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 due to the sale of its assets to Cardinal Health 414, LLC.
Mitigation Strategies
- The Company expects to file the 2016 Form 10-K on or before the fifteenth calendar day following the prescribed due date.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2016-06-30
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Gathering certain required documentation for the Quarterly Report on Form 10-Q for the quarter ended June 30, 2016.